Simulated Y-site compatibility of atosiban acetate with selected intravenous drugs

被引:0
|
作者
Jimenez-Lozano, Ines [1 ]
Larrosa-Garcia, Maria [1 ]
Boix-Montanes, Antoni [2 ]
Clemente Bautista, Susana [1 ]
Cabanas Poy, Maria Josep [1 ]
机构
[1] Vail dHebron Univ Hosp, Pharm Dept, Passeig Vall Hebron 119-129, Barcelona, Spain
[2] Univ Barcelona, Fac Pharm & Food Sci, Pharm & Pharmaceut Technol, Barcelona, Spain
关键词
Atosiban; Y-site compatibility; Parenteral administration;
D O I
10.1016/j.ejogrb.2022.06.006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The physical compatibility of atosiban and selected drugs during simulated Y-site administration was evaluated. We also searched for any compatibility predictions regarding its physicochemical properties. Study design: Test admixtures were prepared by mixing 5 mL of each study drug solution with 5 mL of atosiban solution in a 1:1 ratio to simulate Y-site infusion. Assessments were made immediately after mixing (baseline), and at 0.5, 1, and 3 h. Visual incompatibility was defined as a presence of haze or any visible particulate matter, gas formation, or colour change. Turbidity and pH variation of the admixtures were also assessed using instrumental methods. Results: None of the admixtures used with atosiban exhibited visual changes and no incompatibility regarding instrumental methods were observed, because no admixture had an increase of 0.5 nephelometric turbidity units, and no pH change was above one unit when compared to baseline. However, the pH of ampicillin and omeprazole admixtures fell outside of the atosiban stability range. Conclusions: Our study showed no physical incompatibility between atosiban and the test drugs in terms of visual changes or nephelometric and pH measurements. However, we recommend against atosiban and ampicillin or omeprazole coadministration until complementary compatibility studies are performed.
引用
收藏
页码:106 / 109
页数:4
相关论文
共 50 条
  • [1] COMPATIBILITY OF FILGRASTIM WITH SELECTED DRUGS DURING SIMULATED Y-SITE ADMINISTRATION
    TRISSEL, LA
    MARTINEZ, JF
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (15): : 1907 - 1913
  • [2] COMPATIBILITY OF AZTREONAM WITH SELECTED DRUGS DURING SIMULATED Y-SITE ADMINISTRATION
    TRISSEL, LA
    MARTINEZ, JF
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (10) : 1086 - 1090
  • [3] COMPATIBILITY OF AMIFOSTINE WITH SELECTED DRUGS DURING SIMULATED Y-SITE ADMINISTRATION
    TRISSEL, LA
    MARTINEZ, JF
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (20) : 2208 - 2212
  • [4] Visual compatibility of blinatumomab with selected drugs during simulated Y-site administration
    Du Repaire, Theau
    Vigne, Petula
    Guedon, Amaury
    Fanciullino, Raphaelle
    Gauthier-Villano, Laurence
    Peres, Pierre Bertault
    Pourroy, Bertrand
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (16) : 1217 - 1218
  • [5] VISUAL COMPATIBILITY OF AMSACRINE WITH SELECTED DRUGS DURING SIMULATED Y-SITE INJECTION
    TRISSEL, LA
    CHANDLER, SW
    FOLSTAD, JT
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (11): : 2525 - 2528
  • [6] PHYSICAL COMPATIBILITY OF MELPHALAN WITH SELECTED DRUGS DURING SIMULATED Y-SITE ADMINISTRATION
    TRISSEL, LA
    MARTINEZ, JF
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (11): : 2359 - 2363
  • [7] Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration
    Trissel, LA
    Martinez, JF
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (09) : 1041 - 1045
  • [8] Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration
    Hall, PD
    Yui, D
    Lyons, S
    Bosso, JA
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (02) : 185 - 189
  • [9] Visual compatibility of defibrotide with selected drugs during simulated Y-site administration
    Correard, Florian
    Savry, Amandine
    Gauthier-Villano, Laurence
    Pisano, Pascale
    Pourroy, Bertrand
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (15) : 1288 - 1291
  • [10] Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration
    Chan, Pak
    Bishop, Amanda
    Kuplec, Thomas C.
    Trissel, Lawrence A.
    Gole, Dilip
    Jimidar, Ilias M.
    Vermeersch, Hans
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (16) : 1545 - 1551